Lucas Ward
Stock Analyst at Ascendiant
(0.03)
# 4,627
Out of 4,629 analysts
57
Total ratings
10%
Success rate
-56.6%
Average return
Main Sectors:
Stocks Rated by Lucas Ward
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| VVOS Vivos Therapeutics | Reiterated: Buy | $3 → $3.1 | $0.324 | +856.79% | 12 | Jun 4, 2026 | |
| ACON Aclarion | Maintained: Buy | $7 → $7.5 | $2.29 | +227.51% | 8 | May 28, 2026 | |
| SXTP 60 Degrees Pharmaceuticals | Maintained: Buy | $4.2 → $3.7 | $1.12 | +230.36% | 10 | May 22, 2026 | |
| LIQT LiqTech International | Maintained: Buy | $4.3 → $4.4 | $0.637 | +590.74% | 10 | May 20, 2026 | |
| HSCS HeartSciences | Maintained: Buy | $9.2 → $8 | $2.02 | +296.04% | 12 | Mar 23, 2026 | |
| VMAR Vision Marine Technologies | Maintained: Buy | $30 → $10 | $0.6577 | n/a | 5 | Apr 30, 2025 |
Vivos Therapeutics
Jun 4, 2026
Reiterated: Buy
Price Target: $3 → $3.1
Current: $0.324
Upside: +856.79%
Aclarion
May 28, 2026
Maintained: Buy
Price Target: $7 → $7.5
Current: $2.29
Upside: +227.51%
60 Degrees Pharmaceuticals
May 22, 2026
Maintained: Buy
Price Target: $4.2 → $3.7
Current: $1.12
Upside: +230.36%
LiqTech International
May 20, 2026
Maintained: Buy
Price Target: $4.3 → $4.4
Current: $0.637
Upside: +590.74%
HeartSciences
Mar 23, 2026
Maintained: Buy
Price Target: $9.2 → $8
Current: $2.02
Upside: +296.04%
Vision Marine Technologies
Apr 30, 2025
Maintained: Buy
Price Target: $30 → $10
Current: $0.6577
Upside: n/a